 Markus Wimmer
Concepts (462)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gait | 38 | 2020 | 395 | 9.280 |
Why?
| | Hip Prosthesis | 34 | 2022 | 569 | 6.250 |
Why?
| | Knee Prosthesis | 22 | 2020 | 237 | 5.420 |
Why?
| | Arthroplasty, Replacement, Knee | 22 | 2021 | 668 | 5.410 |
Why?
| | Knee Joint | 31 | 2020 | 775 | 5.170 |
Why?
| | Prosthesis Failure | 32 | 2021 | 534 | 4.770 |
Why?
| | Polyethylene | 19 | 2020 | 127 | 4.690 |
Why?
| | Walking | 14 | 2022 | 249 | 4.380 |
Why?
| | Arthroplasty, Replacement, Hip | 30 | 2021 | 840 | 4.340 |
Why?
| | Models, Biological | 16 | 2018 | 428 | 3.430 |
Why?
| | Biocompatible Materials | 13 | 2020 | 112 | 3.340 |
Why?
| | Materials Testing | 24 | 2021 | 140 | 3.240 |
Why?
| | Biomechanical Phenomena | 38 | 2022 | 719 | 3.240 |
Why?
| | Equipment Failure Analysis | 21 | 2016 | 116 | 3.170 |
Why?
| | Polyethylenes | 12 | 2020 | 41 | 3.130 |
Why?
| | Osteoarthritis, Hip | 12 | 2018 | 97 | 3.110 |
Why?
| | Cartilage, Articular | 16 | 2020 | 586 | 2.780 |
Why?
| | Hip Joint | 13 | 2016 | 339 | 2.770 |
Why?
| | Prosthesis Design | 22 | 2021 | 511 | 2.400 |
Why?
| | Titanium | 16 | 2021 | 204 | 2.360 |
Why?
| | Alloys | 16 | 2021 | 96 | 2.300 |
Why?
| | Range of Motion, Articular | 17 | 2019 | 703 | 2.230 |
Why?
| | Tibia | 9 | 2020 | 266 | 1.930 |
Why?
| | Humans | 114 | 2022 | 31481 | 1.840 |
Why?
| | Protein Tyrosine Phosphatases | 4 | 2014 | 8 | 1.840 |
Why?
| | Shoes | 5 | 2022 | 29 | 1.830 |
Why?
| | Metals | 9 | 2022 | 157 | 1.790 |
Why?
| | Osteoarthritis, Knee | 12 | 2019 | 366 | 1.780 |
Why?
| | Stress, Mechanical | 22 | 2020 | 198 | 1.700 |
Why?
| | Surface Properties | 29 | 2021 | 139 | 1.690 |
Why?
| | Knee | 7 | 2017 | 46 | 1.680 |
Why?
| | Corrosion | 18 | 2022 | 127 | 1.600 |
Why?
| | Middle Aged | 52 | 2020 | 11209 | 1.590 |
Why?
| | Chondrocytes | 9 | 2015 | 216 | 1.550 |
Why?
| | Mechanical Phenomena | 7 | 2022 | 24 | 1.500 |
Why?
| | Male | 60 | 2020 | 17583 | 1.500 |
Why?
| | Europium | 3 | 2020 | 5 | 1.420 |
Why?
| | Stearates | 3 | 2020 | 5 | 1.420 |
Why?
| | Aged | 45 | 2022 | 10295 | 1.400 |
Why?
| | Female | 58 | 2021 | 18253 | 1.370 |
Why?
| | Steel | 2 | 2020 | 2 | 1.360 |
Why?
| | Aluminum Oxide | 3 | 2019 | 7 | 1.320 |
Why?
| | Pressure | 6 | 2020 | 71 | 1.320 |
Why?
| | Vitallium | 6 | 2013 | 19 | 1.230 |
Why?
| | Weight-Bearing | 18 | 2020 | 193 | 1.200 |
Why?
| | Nickel | 3 | 2021 | 30 | 1.200 |
Why?
| | Prostheses and Implants | 8 | 2016 | 166 | 1.140 |
Why?
| | Dental Implants | 3 | 2012 | 8 | 1.090 |
Why?
| | Aged, 80 and over | 24 | 2020 | 5234 | 1.010 |
Why?
| | Anterior Cruciate Ligament | 3 | 2018 | 268 | 0.980 |
Why?
| | Postoperative Complications | 5 | 2017 | 1083 | 0.960 |
Why?
| | Electromyography | 7 | 2018 | 93 | 0.960 |
Why?
| | Muscle, Skeletal | 11 | 2018 | 385 | 0.950 |
Why?
| | Bioreactors | 4 | 2014 | 9 | 0.930 |
Why?
| | Movement | 8 | 2016 | 167 | 0.920 |
Why?
| | Cell Culture Techniques | 4 | 2014 | 52 | 0.910 |
Why?
| | Cobalt | 8 | 2016 | 111 | 0.900 |
Why?
| | Chromium | 7 | 2016 | 95 | 0.890 |
Why?
| | Arthroplasty, Replacement | 3 | 2020 | 147 | 0.890 |
Why?
| | Metal-on-Metal Joint Prostheses | 5 | 2014 | 54 | 0.880 |
Why?
| | Mitochondrial Proteins | 2 | 2011 | 46 | 0.840 |
Why?
| | Adult | 28 | 2019 | 9779 | 0.810 |
Why?
| | Femur | 6 | 2019 | 389 | 0.800 |
Why?
| | Ankle Injuries | 3 | 2016 | 11 | 0.790 |
Why?
| | Feedback, Sensory | 1 | 2019 | 7 | 0.780 |
Why?
| | Proteoglycans | 5 | 2017 | 419 | 0.780 |
Why?
| | Foot | 2 | 2016 | 35 | 0.770 |
Why?
| | Joint Prosthesis | 2 | 2018 | 77 | 0.770 |
Why?
| | Arthroplasty, Replacement, Ankle | 1 | 2018 | 2 | 0.750 |
Why?
| | Friction | 10 | 2020 | 18 | 0.730 |
Why?
| | Feedback | 2 | 2016 | 26 | 0.720 |
Why?
| | Cattle | 13 | 2020 | 260 | 0.690 |
Why?
| | Animals | 27 | 2021 | 5312 | 0.690 |
Why?
| | Lipopolysaccharides | 3 | 2013 | 138 | 0.680 |
Why?
| | Device Removal | 6 | 2020 | 101 | 0.680 |
Why?
| | Electrochemistry | 9 | 2017 | 43 | 0.670 |
Why?
| | Cicatrix | 1 | 2016 | 13 | 0.650 |
Why?
| | Stainless Steel | 4 | 2021 | 18 | 0.620 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2014 | 5 | 0.620 |
Why?
| | Synovial Fluid | 5 | 2021 | 138 | 0.620 |
Why?
| | 14-3-3 Proteins | 2 | 2014 | 6 | 0.620 |
Why?
| | Joints | 2 | 2016 | 101 | 0.610 |
Why?
| | Recovery of Function | 4 | 2014 | 309 | 0.600 |
Why?
| | Auditory Perception | 1 | 2016 | 49 | 0.590 |
Why?
| | Purkinje Cells | 1 | 2014 | 2 | 0.590 |
Why?
| | Cartilage | 2 | 2019 | 168 | 0.570 |
Why?
| | Severity of Illness Index | 4 | 2013 | 1240 | 0.540 |
Why?
| | Hyperkinesis | 1 | 2013 | 12 | 0.540 |
Why?
| | Metals, Heavy | 1 | 2013 | 4 | 0.530 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2013 | 20 | 0.530 |
Why?
| | RNA, Messenger | 7 | 2014 | 371 | 0.530 |
Why?
| | Algorithms | 2 | 2014 | 412 | 0.520 |
Why?
| | Motion | 3 | 2011 | 28 | 0.520 |
Why?
| | Radiography | 8 | 2018 | 717 | 0.520 |
Why?
| | Beryllium | 1 | 2013 | 1 | 0.520 |
Why?
| | Microscopy, Electron, Scanning | 11 | 2013 | 81 | 0.510 |
Why?
| | Rotation | 6 | 2019 | 158 | 0.510 |
Why?
| | Acetabulum | 5 | 2012 | 195 | 0.510 |
Why?
| | Prosthesis-Related Infections | 3 | 2021 | 209 | 0.510 |
Why?
| | Blood Proteins | 1 | 2012 | 23 | 0.500 |
Why?
| | Baseball | 4 | 2017 | 104 | 0.490 |
Why?
| | Mouth | 1 | 2012 | 15 | 0.490 |
Why?
| | Computer Simulation | 6 | 2020 | 249 | 0.490 |
Why?
| | Memory | 1 | 2014 | 343 | 0.480 |
Why?
| | Hippocampus | 1 | 2014 | 295 | 0.470 |
Why?
| | Activities of Daily Living | 1 | 2015 | 495 | 0.470 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 32 | 0.470 |
Why?
| | Glioblastoma | 1 | 2011 | 25 | 0.460 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 46 | 0.460 |
Why?
| | Microcirculation | 5 | 2007 | 40 | 0.450 |
Why?
| | Particle Size | 7 | 2013 | 71 | 0.450 |
Why?
| | Glycoproteins | 3 | 2007 | 65 | 0.450 |
Why?
| | Gene Expression | 2 | 2015 | 272 | 0.440 |
Why?
| | Fragile X Syndrome | 1 | 2013 | 178 | 0.430 |
Why?
| | Zirconium | 2 | 2019 | 6 | 0.410 |
Why?
| | Transplants | 1 | 2009 | 11 | 0.410 |
Why?
| | Brain Neoplasms | 1 | 2011 | 187 | 0.410 |
Why?
| | Graft Survival | 1 | 2009 | 111 | 0.390 |
Why?
| | Surgery, Computer-Assisted | 2 | 2006 | 61 | 0.380 |
Why?
| | Risk Factors | 8 | 2017 | 2664 | 0.380 |
Why?
| | Muscle Strength | 5 | 2019 | 134 | 0.380 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 389 | 0.380 |
Why?
| | Carcinoma, Basal Cell | 1 | 2008 | 7 | 0.380 |
Why?
| | Keratinocytes | 1 | 2008 | 12 | 0.380 |
Why?
| | Equipment Design | 5 | 2019 | 198 | 0.370 |
Why?
| | Ankle Joint | 4 | 2016 | 44 | 0.370 |
Why?
| | Hydrogen-Ion Concentration | 8 | 2021 | 177 | 0.370 |
Why?
| | Dental Alloys | 3 | 2013 | 4 | 0.370 |
Why?
| | Stromal Cells | 1 | 2008 | 39 | 0.370 |
Why?
| | Models, Theoretical | 2 | 2020 | 112 | 0.370 |
Why?
| | Osteolysis | 3 | 2016 | 141 | 0.370 |
Why?
| | Time Factors | 12 | 2016 | 1902 | 0.370 |
Why?
| | Reoperation | 7 | 2014 | 938 | 0.360 |
Why?
| | Hyaluronic Acid | 3 | 2021 | 108 | 0.360 |
Why?
| | Nitrogen | 2 | 2021 | 5 | 0.350 |
Why?
| | Polyurethanes | 2 | 2006 | 10 | 0.350 |
Why?
| | Adaptation, Biological | 1 | 2007 | 3 | 0.350 |
Why?
| | Skin Neoplasms | 1 | 2008 | 85 | 0.350 |
Why?
| | Synovial Membrane | 1 | 2007 | 79 | 0.340 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 207 | 0.320 |
Why?
| | Molybdenum | 4 | 2016 | 21 | 0.320 |
Why?
| | In Vitro Techniques | 3 | 2016 | 248 | 0.310 |
Why?
| | Joint Diseases | 1 | 2007 | 114 | 0.310 |
Why?
| | Femur Head | 1 | 2006 | 58 | 0.310 |
Why?
| | Elbow Joint | 3 | 2015 | 132 | 0.310 |
Why?
| | Implants, Experimental | 2 | 2021 | 29 | 0.310 |
Why?
| | Microscopy, Electron, Transmission | 5 | 2013 | 30 | 0.310 |
Why?
| | Exercise Test | 1 | 2006 | 123 | 0.300 |
Why?
| | Case-Control Studies | 5 | 2016 | 687 | 0.300 |
Why?
| | Saliva, Artificial | 4 | 2013 | 4 | 0.300 |
Why?
| | Foreign Bodies | 2 | 2003 | 25 | 0.300 |
Why?
| | Tissue Engineering | 2 | 2006 | 50 | 0.290 |
Why?
| | Joint Instability | 1 | 2009 | 374 | 0.290 |
Why?
| | Foreign-Body Reaction | 3 | 2014 | 31 | 0.290 |
Why?
| | Mechanotransduction, Cellular | 1 | 2004 | 6 | 0.290 |
Why?
| | Immunohistochemistry | 3 | 2011 | 494 | 0.280 |
Why?
| | Cell Survival | 3 | 2017 | 181 | 0.280 |
Why?
| | Microspheres | 1 | 2004 | 30 | 0.280 |
Why?
| | Reference Values | 3 | 2017 | 260 | 0.280 |
Why?
| | Finite Element Analysis | 3 | 2020 | 71 | 0.270 |
Why?
| | Physical Examination | 2 | 2015 | 116 | 0.270 |
Why?
| | Treatment Outcome | 10 | 2016 | 3910 | 0.270 |
Why?
| | Spinal Diseases | 1 | 2006 | 153 | 0.270 |
Why?
| | Metal Nanoparticles | 3 | 2013 | 10 | 0.270 |
Why?
| | Up-Regulation | 4 | 2011 | 220 | 0.260 |
Why?
| | Reproducibility of Results | 5 | 2022 | 886 | 0.260 |
Why?
| | Intervertebral Disc | 1 | 2006 | 243 | 0.260 |
Why?
| | Cells, Cultured | 4 | 2014 | 802 | 0.260 |
Why?
| | Young Adult | 7 | 2016 | 2277 | 0.250 |
Why?
| | Shoulder Joint | 3 | 2015 | 560 | 0.250 |
Why?
| | Sensitivity and Specificity | 4 | 2012 | 580 | 0.250 |
Why?
| | Bone Cements | 3 | 2012 | 91 | 0.240 |
Why?
| | Transplantation, Homologous | 2 | 2017 | 292 | 0.240 |
Why?
| | Ceramics | 2 | 2019 | 22 | 0.240 |
Why?
| | Internationality | 3 | 2012 | 26 | 0.240 |
Why?
| | Analysis of Variance | 3 | 2012 | 364 | 0.230 |
Why?
| | Healthy Volunteers | 2 | 2019 | 50 | 0.230 |
Why?
| | Lubrication | 3 | 2020 | 5 | 0.220 |
Why?
| | Pain | 4 | 2013 | 336 | 0.220 |
Why?
| | In Situ Hybridization | 2 | 2011 | 63 | 0.220 |
Why?
| | Osseointegration | 1 | 2021 | 72 | 0.220 |
Why?
| | Inflammation | 3 | 2020 | 360 | 0.220 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 191 | 0.210 |
Why?
| | Mass Spectrometry | 1 | 2000 | 43 | 0.210 |
Why?
| | Mice | 3 | 2021 | 1894 | 0.210 |
Why?
| | Cross-Linking Reagents | 2 | 2011 | 17 | 0.200 |
Why?
| | Nebulizers and Vaporizers | 1 | 2000 | 21 | 0.200 |
Why?
| | Brain | 1 | 2009 | 1655 | 0.200 |
Why?
| | Carbon | 3 | 2013 | 8 | 0.190 |
Why?
| | Staphylococcal Infections | 1 | 2021 | 176 | 0.190 |
Why?
| | Muscle Contraction | 2 | 2015 | 84 | 0.190 |
Why?
| | Follow-Up Studies | 2 | 2017 | 2028 | 0.180 |
Why?
| | Feasibility Studies | 2 | 2016 | 281 | 0.180 |
Why?
| | Bone Density | 2 | 2011 | 141 | 0.180 |
Why?
| | Risk Assessment | 2 | 2012 | 806 | 0.180 |
Why?
| | Proprioception | 2 | 2014 | 21 | 0.170 |
Why?
| | Shoulder | 2 | 2017 | 156 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 38 | 0.170 |
Why?
| | Reference Standards | 3 | 2018 | 38 | 0.170 |
Why?
| | Body Mass Index | 2 | 2018 | 458 | 0.160 |
Why?
| | Lower Extremity | 1 | 2017 | 37 | 0.160 |
Why?
| | Extremities | 1 | 2016 | 30 | 0.160 |
Why?
| | Mesocricetus | 6 | 2007 | 8 | 0.160 |
Why?
| | Upper Extremity | 1 | 2017 | 46 | 0.160 |
Why?
| | Principal Component Analysis | 1 | 2016 | 27 | 0.160 |
Why?
| | Spectrum Analysis | 3 | 2011 | 10 | 0.160 |
Why?
| | Cricetinae | 6 | 2007 | 52 | 0.160 |
Why?
| | Escherichia coli | 2 | 2013 | 66 | 0.160 |
Why?
| | Rheology | 2 | 2006 | 3 | 0.160 |
Why?
| | Deltoid Muscle | 1 | 2015 | 6 | 0.150 |
Why?
| | Gene Expression Regulation | 3 | 2009 | 351 | 0.150 |
Why?
| | Thigh | 1 | 2015 | 36 | 0.150 |
Why?
| | Age Factors | 2 | 2016 | 943 | 0.150 |
Why?
| | Pilot Projects | 3 | 2013 | 455 | 0.150 |
Why?
| | Patient Positioning | 1 | 2015 | 35 | 0.150 |
Why?
| | Allografts | 1 | 2017 | 171 | 0.150 |
Why?
| | Genome, Human | 1 | 2015 | 52 | 0.150 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 2014 | 2 | 0.150 |
Why?
| | Diacylglycerol Kinase | 1 | 2014 | 4 | 0.150 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 9 | 0.150 |
Why?
| | Protein Transport | 1 | 2014 | 42 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2015 | 94 | 0.140 |
Why?
| | Quadriceps Muscle | 2 | 2016 | 27 | 0.140 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 43 | 0.140 |
Why?
| | Autopsy | 1 | 2016 | 340 | 0.140 |
Why?
| | Cytokines | 1 | 2017 | 364 | 0.140 |
Why?
| | Oxidation-Reduction | 2 | 2011 | 79 | 0.140 |
Why?
| | NF-kappa B | 1 | 2014 | 112 | 0.140 |
Why?
| | Pyramidal Cells | 1 | 2014 | 46 | 0.140 |
Why?
| | Mitochondria | 1 | 2014 | 91 | 0.140 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 178 | 0.140 |
Why?
| | Gamma Rays | 2 | 2011 | 17 | 0.140 |
Why?
| | Dental Materials | 1 | 2013 | 3 | 0.140 |
Why?
| | Cell Line | 1 | 2014 | 360 | 0.130 |
Why?
| | Interferometry | 2 | 2013 | 4 | 0.130 |
Why?
| | Microscopy, Electrochemical, Scanning | 1 | 2013 | 1 | 0.130 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 58 | 0.130 |
Why?
| | Child | 3 | 2015 | 1572 | 0.130 |
Why?
| | Foot Orthoses | 1 | 2013 | 12 | 0.130 |
Why?
| | Molecular Weight | 3 | 2010 | 58 | 0.130 |
Why?
| | Bone Malalignment | 1 | 2013 | 20 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2014 | 230 | 0.130 |
Why?
| | Macrophages | 1 | 2014 | 129 | 0.120 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 222 | 0.120 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 548 | 0.120 |
Why?
| | Rotator Cuff | 1 | 2015 | 252 | 0.120 |
Why?
| | Sleep | 1 | 2016 | 357 | 0.120 |
Why?
| | Shear Strength | 1 | 2012 | 8 | 0.120 |
Why?
| | Graphite | 1 | 2011 | 1 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2011 | 6 | 0.120 |
Why?
| | src-Family Kinases | 1 | 2011 | 9 | 0.120 |
Why?
| | Germany | 1 | 2011 | 12 | 0.120 |
Why?
| | Somatosensory Disorders | 1 | 2012 | 10 | 0.120 |
Why?
| | Tenodesis | 1 | 2014 | 143 | 0.120 |
Why?
| | Orthopedics | 2 | 2012 | 133 | 0.120 |
Why?
| | Aluminum | 1 | 2011 | 11 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 60 | 0.120 |
Why?
| | Vibration | 1 | 2012 | 29 | 0.120 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 10 | 0.120 |
Why?
| | Neoplasm Grading | 1 | 2011 | 63 | 0.110 |
Why?
| | Adolescent | 3 | 2015 | 2667 | 0.110 |
Why?
| | Prosthesis Fitting | 1 | 2011 | 23 | 0.110 |
Why?
| | Microscopy, Electron | 1 | 2011 | 100 | 0.110 |
Why?
| | Athletic Performance | 1 | 2011 | 22 | 0.110 |
Why?
| | Coated Materials, Biocompatible | 1 | 2011 | 41 | 0.110 |
Why?
| | Osteoarthritis | 1 | 2015 | 369 | 0.110 |
Why?
| | Poloxamer | 1 | 2010 | 3 | 0.110 |
Why?
| | Surface-Active Agents | 1 | 2010 | 7 | 0.110 |
Why?
| | Fractures, Cartilage | 1 | 2010 | 4 | 0.110 |
Why?
| | Apoptosis | 2 | 2010 | 292 | 0.110 |
Why?
| | Logistic Models | 1 | 2012 | 479 | 0.110 |
Why?
| | Musculoskeletal System | 1 | 2010 | 6 | 0.110 |
Why?
| | Suture Anchors | 1 | 2011 | 59 | 0.110 |
Why?
| | Anisotropy | 1 | 2010 | 58 | 0.110 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 43 | 0.110 |
Why?
| | Zygapophyseal Joint | 1 | 2010 | 47 | 0.100 |
Why?
| | Neurophysins | 1 | 2009 | 1 | 0.100 |
Why?
| | Dermoscopy | 1 | 2009 | 1 | 0.100 |
Why?
| | Vasopressins | 1 | 2009 | 6 | 0.100 |
Why?
| | Elasticity | 2 | 2004 | 53 | 0.100 |
Why?
| | Immunoblotting | 1 | 2009 | 65 | 0.100 |
Why?
| | Glycosaminoglycans | 1 | 2009 | 69 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2006 | 33 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2009 | 102 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 148 | 0.100 |
Why?
| | Collagen | 1 | 2009 | 111 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2006 | 188 | 0.100 |
Why?
| | Chromium Compounds | 1 | 2009 | 5 | 0.100 |
Why?
| | Capillaries | 3 | 2005 | 15 | 0.100 |
Why?
| | Cadaver | 2 | 2010 | 356 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2009 | 107 | 0.100 |
Why?
| | Hypersensitivity, Delayed | 1 | 2009 | 19 | 0.100 |
Why?
| | Transplantation, Autologous | 1 | 2009 | 223 | 0.100 |
Why?
| | Athletic Injuries | 1 | 2011 | 182 | 0.100 |
Why?
| | Phosphates | 1 | 2009 | 21 | 0.100 |
Why?
| | Tissue Scaffolds | 1 | 2009 | 27 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2010 | 116 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2009 | 124 | 0.100 |
Why?
| | Chicago | 1 | 2012 | 955 | 0.090 |
Why?
| | Tendon Injuries | 1 | 2011 | 189 | 0.090 |
Why?
| | Light | 1 | 2009 | 77 | 0.090 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 63 | 0.090 |
Why?
| | Diskectomy | 1 | 2010 | 181 | 0.090 |
Why?
| | Chromium Alloys | 2 | 2017 | 48 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2020 | 3591 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2011 | 322 | 0.090 |
Why?
| | Bone Transplantation | 1 | 2009 | 231 | 0.080 |
Why?
| | Cyanates | 1 | 2006 | 1 | 0.080 |
Why?
| | Isocyanates | 1 | 2006 | 1 | 0.080 |
Why?
| | Isosorbide | 1 | 2006 | 2 | 0.080 |
Why?
| | Matrilin Proteins | 1 | 2006 | 3 | 0.080 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2006 | 5 | 0.080 |
Why?
| | Disease Progression | 3 | 2018 | 861 | 0.080 |
Why?
| | Polyesters | 1 | 2006 | 7 | 0.080 |
Why?
| | Biophysical Phenomena | 1 | 2006 | 35 | 0.080 |
Why?
| | Arthrography | 1 | 2006 | 26 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2006 | 38 | 0.080 |
Why?
| | Pain Measurement | 3 | 2018 | 476 | 0.080 |
Why?
| | Collagen Type II | 1 | 2006 | 36 | 0.080 |
Why?
| | Biophysics | 1 | 2006 | 44 | 0.080 |
Why?
| | Polymers | 1 | 2006 | 38 | 0.080 |
Why?
| | Porosity | 1 | 2006 | 69 | 0.080 |
Why?
| | Single-Blind Method | 1 | 2006 | 132 | 0.080 |
Why?
| | Orientation | 1 | 2006 | 33 | 0.080 |
Why?
| | Permeability | 2 | 2005 | 143 | 0.080 |
Why?
| | Aggrecans | 1 | 2006 | 200 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2006 | 176 | 0.080 |
Why?
| | Debridement | 1 | 2006 | 99 | 0.080 |
Why?
| | Robotics | 1 | 2005 | 17 | 0.080 |
Why?
| | Treatment Failure | 1 | 2006 | 187 | 0.070 |
Why?
| | Leukocytes | 4 | 2007 | 50 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2005 | 79 | 0.070 |
Why?
| | Physical Stimulation | 1 | 2004 | 17 | 0.070 |
Why?
| | Lumbar Vertebrae | 1 | 2010 | 469 | 0.070 |
Why?
| | Posture | 3 | 2015 | 92 | 0.070 |
Why?
| | Arthroplasty | 1 | 2005 | 125 | 0.070 |
Why?
| | Proteins | 1 | 2005 | 94 | 0.070 |
Why?
| | Extracellular Matrix | 1 | 2004 | 92 | 0.070 |
Why?
| | Electrochemical Techniques | 2 | 2013 | 7 | 0.070 |
Why?
| | Prospective Studies | 1 | 2009 | 1934 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2004 | 174 | 0.070 |
Why?
| | Disability Evaluation | 2 | 2019 | 332 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2004 | 232 | 0.060 |
Why?
| | Rest | 1 | 2003 | 33 | 0.060 |
Why?
| | Calibration | 2 | 2000 | 25 | 0.060 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2021 | 14 | 0.060 |
Why?
| | Dielectric Spectroscopy | 2 | 2011 | 2 | 0.060 |
Why?
| | Rats, Zucker | 1 | 2021 | 8 | 0.060 |
Why?
| | Ovariectomy | 1 | 2021 | 29 | 0.060 |
Why?
| | Cohort Studies | 2 | 2019 | 2014 | 0.060 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 87 | 0.060 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 71 | 0.050 |
Why?
| | gamma-Globulins | 1 | 2020 | 1 | 0.050 |
Why?
| | Blood | 1 | 2001 | 30 | 0.050 |
Why?
| | Temperature | 2 | 2012 | 85 | 0.050 |
Why?
| | Albumins | 1 | 2020 | 36 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2020 | 10 | 0.050 |
Why?
| | Neutrophils | 1 | 2021 | 133 | 0.050 |
Why?
| | Spectrophotometry, Atomic | 1 | 2000 | 4 | 0.050 |
Why?
| | Ultrasonics | 1 | 2000 | 17 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 494 | 0.050 |
Why?
| | Omeprazole | 1 | 1999 | 2 | 0.050 |
Why?
| | Anti-Ulcer Agents | 1 | 1999 | 2 | 0.050 |
Why?
| | Famotidine | 1 | 1999 | 2 | 0.050 |
Why?
| | Clarithromycin | 1 | 1999 | 6 | 0.050 |
Why?
| | Helicobacter Infections | 1 | 1999 | 4 | 0.050 |
Why?
| | Metronidazole | 1 | 1999 | 9 | 0.050 |
Why?
| | Helicobacter pylori | 1 | 1999 | 5 | 0.050 |
Why?
| | Forecasting | 1 | 2020 | 134 | 0.050 |
Why?
| | Absorptiometry, Photon | 2 | 2011 | 83 | 0.050 |
Why?
| | Rats | 1 | 2021 | 966 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2021 | 754 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2015 | 986 | 0.050 |
Why?
| | Cell Death | 2 | 2009 | 68 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 1998 | 28 | 0.040 |
Why?
| | Software | 1 | 1998 | 74 | 0.040 |
Why?
| | Muscle Fatigue | 1 | 2017 | 11 | 0.040 |
Why?
| | Hardness | 2 | 2012 | 4 | 0.040 |
Why?
| | Torso | 1 | 2017 | 8 | 0.040 |
Why?
| | Interleukins | 1 | 2017 | 42 | 0.040 |
Why?
| | Electrodes | 1 | 2016 | 16 | 0.040 |
Why?
| | Biosensing Techniques | 1 | 2016 | 13 | 0.040 |
Why?
| | Patellar Ligament | 1 | 1997 | 50 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 227 | 0.040 |
Why?
| | Patella | 1 | 1997 | 77 | 0.040 |
Why?
| | Elbow | 1 | 2017 | 47 | 0.040 |
Why?
| | Independent Living | 1 | 2019 | 257 | 0.040 |
Why?
| | Endothelial Cells | 2 | 2007 | 67 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 412 | 0.040 |
Why?
| | Photography | 1 | 2015 | 18 | 0.040 |
Why?
| | Medical Illustration | 1 | 2015 | 20 | 0.040 |
Why?
| | DNA | 1 | 2015 | 139 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2020 | 1452 | 0.040 |
Why?
| | Body Height | 1 | 2015 | 45 | 0.040 |
Why?
| | Video Recording | 1 | 2015 | 52 | 0.040 |
Why?
| | Capillary Permeability | 2 | 2007 | 28 | 0.040 |
Why?
| | Thorax | 1 | 2014 | 16 | 0.040 |
Why?
| | Exercise | 1 | 2019 | 454 | 0.030 |
Why?
| | Hot Temperature | 1 | 2013 | 26 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 1 | 0.030 |
Why?
| | Diffusion | 1 | 2013 | 28 | 0.030 |
Why?
| | Water | 1 | 2013 | 37 | 0.030 |
Why?
| | Endothelium, Vascular | 2 | 2006 | 72 | 0.030 |
Why?
| | Microscopy, Fluorescence | 2 | 2005 | 112 | 0.030 |
Why?
| | Nanoparticles | 1 | 2013 | 7 | 0.030 |
Why?
| | Knee Injuries | 1 | 2016 | 220 | 0.030 |
Why?
| | Hip Injuries | 1 | 2013 | 11 | 0.030 |
Why?
| | Europe | 1 | 2013 | 88 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 21 | 0.030 |
Why?
| | Microscopy | 1 | 2012 | 14 | 0.030 |
Why?
| | Electrons | 1 | 2012 | 18 | 0.030 |
Why?
| | Spectrum Analysis, Raman | 1 | 2011 | 1 | 0.030 |
Why?
| | Spectroscopy, Electron Energy-Loss | 1 | 2011 | 1 | 0.030 |
Why?
| | Serum | 1 | 2011 | 8 | 0.030 |
Why?
| | Dental Polishing | 1 | 2011 | 1 | 0.030 |
Why?
| | Sodium Hydroxide | 1 | 2011 | 1 | 0.030 |
Why?
| | Sensory Thresholds | 1 | 2012 | 26 | 0.030 |
Why?
| | Lactic Acid | 1 | 2011 | 20 | 0.030 |
Why?
| | Postoperative Care | 1 | 2013 | 141 | 0.030 |
Why?
| | Electric Capacitance | 1 | 2011 | 6 | 0.030 |
Why?
| | Electric Impedance | 1 | 2011 | 28 | 0.030 |
Why?
| | Reducing Agents | 1 | 2010 | 4 | 0.030 |
Why?
| | Free Radicals | 1 | 2010 | 9 | 0.030 |
Why?
| | Rupture | 1 | 2011 | 115 | 0.030 |
Why?
| | Talus | 1 | 2010 | 11 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2010 | 12 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 156 | 0.030 |
Why?
| | Models, Animal | 1 | 2011 | 149 | 0.030 |
Why?
| | Pyridines | 1 | 2010 | 50 | 0.030 |
Why?
| | Suture Techniques | 1 | 2011 | 138 | 0.030 |
Why?
| | Linear Models | 1 | 2011 | 276 | 0.030 |
Why?
| | Regression Analysis | 1 | 2011 | 319 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2010 | 120 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2010 | 160 | 0.030 |
Why?
| | Imidazoles | 1 | 2010 | 74 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 233 | 0.030 |
Why?
| | Torque | 1 | 2009 | 29 | 0.020 |
Why?
| | Wound Healing | 1 | 2010 | 175 | 0.020 |
Why?
| | Cumulative Trauma Disorders | 1 | 2009 | 16 | 0.020 |
Why?
| | Postoperative Period | 1 | 2010 | 295 | 0.020 |
Why?
| | Pain Management | 1 | 2010 | 139 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2007 | 51 | 0.020 |
Why?
| | Signal Transduction | 1 | 2010 | 588 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 128 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2006 | 21 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2006 | 68 | 0.020 |
Why?
| | Microscopy, Video | 1 | 2005 | 7 | 0.020 |
Why?
| | Microfluidics | 1 | 2005 | 7 | 0.020 |
Why?
| | Body Fluids | 1 | 2005 | 21 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2006 | 63 | 0.020 |
Why?
| | Body Weight | 1 | 2006 | 167 | 0.020 |
Why?
| | Hemodynamics | 1 | 2005 | 103 | 0.020 |
Why?
| | Mechanics | 1 | 2005 | 4 | 0.020 |
Why?
| | Nanostructures | 1 | 2005 | 13 | 0.020 |
Why?
| | Oxygen | 1 | 2005 | 94 | 0.020 |
Why?
| | Infant | 1 | 2005 | 642 | 0.020 |
Why?
| | Child, Preschool | 1 | 2005 | 786 | 0.010 |
Why?
| | Monitoring, Physiologic | 1 | 2003 | 100 | 0.010 |
Why?
| | Stomach Ulcer | 1 | 1999 | 5 | 0.010 |
Why?
| | Drug Combinations | 1 | 1999 | 88 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1999 | 96 | 0.010 |
Why?
| | Microbial Sensitivity Tests | 1 | 1999 | 117 | 0.010 |
Why?
|
|
Wimmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|